Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Marko A. Peltoniemi"'
Autor:
M. Valtonen, Marko A. Peltoniemi, Oki Söderholm, Ville-Veikko Hynninen, Tuukka Saarikoski, Minna Kallioinen, Tommi Kauko, Jenni Aittokallio
Publikováno v:
Journal of Perioperative Practice
Since 2013, rotational thromboelastometry has been available in our hospital to assess coagulopathy. The aim of the study was to retrospectively evaluate the effect of thromboelastometry testing in cardiac surgery patients. Altogether 177 patients fr
Autor:
Janne T. Backman, Anri Tienhaara, Mika Kurkela, Tero Vahlberg, Marko A. Peltoniemi, Klaus T. Olkkola, Teijo I. Saari, Alexey Schramko, Martina Havrdová, Jouko Jalonen
Publikováno v:
The Journal of Clinical Pharmacology. 61:522-530
The capability of viscoelastic measurement parameters to screen anticoagulation activity of edoxaban in relation to its plasma concentrations was evaluated in 15 healthy male volunteers. Blood samples were drawn before the oral administration of edox
Autor:
Petteri Kauhanen, Eliisa Löyttyniemi, Hanna von Plato, Marko A. Peltoniemi, Vesa P. Kontinen, Katri Hamunen
Publikováno v:
Acta Anaesthesiologica Scandinavica. 63:1406-1412
BACKGROUND Post-operative pain after an above-knee amputation is often severe, and in the elderly patients the adverse effects of post-operative opioids are evident. We hypothesized that continuous perineural local anesthetic infusion (CPI) combined
Autor:
Vesa P. Kontinen, Kreu Maisniemi, Klaus T. Olkkola, Jukka Mulo, Taru Virtanen, Marko A. Peltoniemi, Teijo I. Saari, Venla Soini, Urmas Savolainen, Antti Liukas, Elina C. V. Brinck, P. Tarkkila, Sanna Mäkelä, Juho Rantakokko, Ville-Veikko Hynninen
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 6, p e0252626 (2021)
PLoS ONE, Vol 16, Iss 6, p e0252626 (2021)
Background Spinal fusion surgery causes severe pain. Strong opioids, commonly used as postoperative analgesics, may have unwanted side effects. S-ketamine may be an effective analgesic adjuvant in opioid patient-controlled analgesia (PCA). However, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01fab95267c6ced01e9fa32ab698f5a9
https://doi.org/10.1101/2021.01.22.21250352
https://doi.org/10.1101/2021.01.22.21250352
Publikováno v:
Clinical Pharmacokinetics. 55:1059-1077
Ketamine is a phencyclidine derivative, which functions primarily as an antagonist of the N-methyl-D-aspartate receptor. It has no affinity for gamma-aminobutyric acid receptors in the central nervous system. Ketamine shows a chiral structure consist
Autor:
Klaus T. Olkkola, Muhammad W. Ashraf, Pertti J. Neuvonen, Teijo I. Saari, Marko A. Peltoniemi
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
Low-dose oral S-ketamine is increasingly used in chronic pain therapy, but extensive cytochrome P450 (CYP) mediated metabolism makes it prone to pharmacokinetic drug-drug interactions (DDIs). In our study, concentration-time data from five studies we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08bd0e0fe746fb0de3167eec7afb03e8
http://hdl.handle.net/10138/299660
http://hdl.handle.net/10138/299660
Autor:
Marko A. Peltoniemi, Nora Hagelberg, Kaisa J. Kurkinen, Teijo I. Saari, Klaus T. Olkkola, Kari Laine, Pertti J. Neuvonen
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 111:325-332
Low-dose ketamine is currently used in several acute and chronic pain conditions as an analgesic. Ketamine undergoes extensive metabolism and is thus susceptible to drug-drug interactions. We examined the effect rifampicin, a well-known inducer of ma
Autor:
Marko A. Peltoniemi, Klaus T. Olkkola, Kari Laine, Nora Hagelberg, Teijo I. Saari, Pertti J. Neuvonen
Publikováno v:
European Journal of Clinical Pharmacology. 68:979-986
We examined the effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of oral S-ketamine. A randomized crossover open-label study design with two phases at an interval of 4 weeks was conducted in 12 healthy volunteers. Grapefruit ju
Autor:
Miia Turpeinen, Marko A. Peltoniemi, Pertti J. Neuvonen, Petri Reponen, Nora Hagelberg, Klaus T. Olkkola, Teijo I. Saari, Kari Laine
Publikováno v:
Clinical Pharmacology & Therapeutics. 90:296-302
This study examined drug–drug interactions of oral S-ketamine with the cytochrome P450 (CYP) 2B6 inhibitor ticlopidine and the CYP3A inhibitor itraconazole. In this randomized, blinded, crossover study, 11 healthy volunteers ingested 0.2 mg/kg S-ke
Autor:
Nora Hagelberg, Teijo I. Saari, Pertti J. Neuvonen, Marko A. Peltoniemi, Klaus T. Olkkola, Kari Laine
Publikováno v:
Fundamental & Clinical Pharmacology. 26:743-750
Ketamine is an intravenous anaesthetic and analgesic agent but it can also be used orally as an adjuvant in the treatment of chronic pain. This study investigated the effect of the herbal antidepressant St John's wort, an inducer of cytochrome P450 3